CD40-modulated dual-specificity phosphatases MAPK phosphatase (MKP)-1 and MKP-3 reciprocally regulate leishmania major infection

Journal of Immunology

Volumn 186, Issue 10, 2011, Pages 5863-5872

  Srivastava, Neetu ^a   Sudan, Raki ^a   Saha, Bhaskar ^a  

^a NATIONAL CENTRE FOR CELL SCIENCE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; MKP 1 PROTEIN; MKP 3 PROTEIN; PHOSPHATASE; SHORT HAIRPIN RNA; TRIPTOLIDE; UNCLASSIFIED DRUG; DITERPENE; DUAL SPECIFICITY PHOSPHATASE 6; EPOXIDE; INTERLEUKIN 10; INTERLEUKIN 12; MITOGEN ACTIVATED PROTEIN KINASE PHOSPHATASE 1; PHENANTHRENE DERIVATIVE; SMALL INTERFERING RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; ENZYME SPECIFICITY; LEISHMANIASIS; MACROPHAGE; MOUSE; NONHUMAN; PARASITE LOAD; PARASITE VIRULENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; UPREGULATION; ANIMAL; BAGG ALBINO MOUSE; GENETICS; IMMUNE EVASION; IMMUNOLOGY; LEISHMANIA MAJOR; METABOLISM; MOUSE MUTANT; PARASITOLOGY; PATHOGENICITY; PHOSPHORYLATION; POLYMERASE CHAIN REACTION; SKIN LEISHMANIASIS;

ANIMALS; ANTIGENS, CD40; DITERPENES; DUAL SPECIFICITY PHOSPHATASE 1; DUAL SPECIFICITY PHOSPHATASE 6; EPOXY COMPOUNDS; IMMUNE EVASION; INTERLEUKIN-10; INTERLEUKIN-12; LEISHMANIA MAJOR; LEISHMANIASIS, CUTANEOUS; MACROPHAGES; MAP KINASE SIGNALING SYSTEM; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHENANTHRENES; PHOSPHORYLATION; POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING;

EID: 79960038324     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1003957     Document Type: Article

References (41)

1. Mathur, R. K., A. Awasthi, P. Wadhone, B. Ramanamurthy, and B. Saha. 2004. Reciprocal CD40 signals through p38MAPK and ERK-1/2 induce counteracting immune responses. Nat. Med. 10:540-544.
2. Mathur, R. K., A. Awasthi, and B. Saha. 2006. The conundrum of CD40 function: host protection or disease promotion? Trends Parasitol. 22:117-122.
3. Rub, A., R. Dey, M. Jadhav, R. Kamat, S. Chakkaramakkil, S. Majumdar, R. Mukhopadhyaya, and B. Saha. 2009. Cholesterol depletion associated with Leishmania major infection alters macrophage CD40 signalosome composition and effector function. [Published erratum appears in 1037-10432009 Nat. Immunol. 10:665.] Nat. Immunol. 10:273-280.
4. Awasthi, A., R. K. Mathur, A. Khan, B. N. Joshi, N. Jain, S. Sawant, R. Boppana, D. Mitra, and B. Saha. 2003. CD40 signaling is impaired in L. major-infected macrophages and is rescued by a p38MAPK activator establishing a hostprotective memory T cell response. J. Exp. Med. 197:1037-1043.
5. Blanchette, J., N. R. Racette, R. Faure, K. A. Siminovitch, and M. Olivier. 1999. Leishmania-induced increases in activation of macrophage SHP-1 tyrosine phosphatase are associated with impaired IFN-g-triggered JAK2 activation. Eur. J. Immunol. 29:3737-3744.
6. Nandan, D., T. Yi, M. Lopez, C. Lai, and N. E. Reiner. 2002. Leishmania EF-1a activates the Src homology 2 domain containing tyrosine phosphatase SHP-1 leading to macrophage deactivation. J. Biol. Chem. 277:50190-50197.
7. Olivier, M., D. J. Gregory, and G. Forget. 2005. Subversion mechanisms by which Leishmania parasites can escape the host immune response: a signaling point of view. Clin. Microbiol. Rev. 18:293-305.
8. Blanchette, J., I. Abu-Dayyeh, K. Hassani, L. Whitcombe, and M. Olivier. 2009. Regulation of macrophage nitric oxide production by the protein tyrosine phosphatase Src homology 2 domain phosphotyrosine phosphatase 1 (SHP-1). Immunology 127:123-133.
9. Forget, G., C. Matte, K. A. Siminovitch, S. Rivest, P. Pouliot, and M. Olivier. 2005. Regulation of the Leishmania-induced innate inflammatory response by the protein tyrosine phosphatase SHP-1. Eur. J. Immunol. 35:1906-1917.
10. Keyse, S. M. 2000. Protein phosphatases and the regulation of mitogen-activated protein kinase signalling. Curr. Opin. Cell Biol. 12:186-192.
11. Theodosiou, A., and A. Ashworth. 2002. MAP kinase phosphatases. Genome Biol. 3: reviews3009.1-3009.10.
12. Liu, Y., E. G. Shepherd, and L. D. Nelin. 2007. MAPK phosphatases: regulating the immune response. Nat. Rev. Immunol. 7:202-212.
13. Hammer, M., J. Mages, H. Dietrich, A. Servatius, N. Howells, A. C. Cato, and R. Lang. 2006. Dual specificity phosphatase 1 (DUSP1) regulates a subset of LPS-induced genes and protects mice from lethal endotoxin shock. J. Exp. Med. 203:15-20.
14. Chen, P., J. Li, J. Barnes, G. C. Kokkonen, J. C. Lee, and Y. Liu. 2002. Restraint of proinflammatory cytokine biosynthesis by mitogen-activated protein kinase phosphatase-1 in lipopolysaccharide-stimulated macrophages. J. Immunol. 169:6408-6416.
15. Salojin, K. V., I. B. Owusu, K. A. Millerchip, M. Potter, K. A. Platt, and T. Oravecz. 2006. Essential role of MAPK phosphatase-1 in the negative control of innate immune responses. J. Immunol. 176:1899-1907.
16. Chi, H., S. P. Barry, R. J. Roth, J. J. Wu, E. A. Jones, A. M. Bennett, and R. A. Flavell. 2006. Dynamic regulation of pro- and anti-inflammatory cytokines by MAPK phosphatase 1 (MKP-1) in innate immune responses. Proc. Natl. Acad. Sci. USA 103:2274-2279.
17. Maillet, M., N. H. Purcell, M. A. Sargent, A. J. York, O. F. Bueno, and J. D. Molkentin. 2008. DUSP6 (MKP3) null mice show enhanced ERK1/2 phosphorylation at baseline and increased myocyte proliferation in the heart affecting disease susceptibility. J. Biol. Chem. 283:31246-31255.
18. Guan, K. L., S. S. Broyles, and J. E. Dixon. 1991. A Tyr/Ser protein phosphatase encoded by vaccinia virus. Nature 350:359-362.
19. Shepherd, E. G., Q. Zhao, S. E. Welty, T. N. Hansen, C. V. Smith, and Y. Liu. 2004. The function of mitogen-activated protein kinase phosphatase-1 in peptidoglycan-stimulated macrophages. J. Biol. Chem. 279:54023-54031.
20. Murray, H. W., and C. F. Nathan. 1999. Macrophage microbicidal mechanisms in vivo: reactive nitrogen versus oxygen intermediates in the killing of intracellular visceral Leishmania donovani. J. Exp. Med. 189:741-746.
21. Carrera, L., R. T. Gazzinelli, R. Badolato, S. Hieny, W. Muller, R. Kuhn, and D. L. Sacks. 1996. Leishmania promastigotes selectively inhibit interleukin 12 induction in bone marrow-derived macrophages from susceptible and resistant mice. J. Exp. Med. 183:515-526.
22. Chatelain, R., S. Mauze, and R. L. Coffman. 1999. Experimental Leishmania major infection in mice: role of IL-10. Parasite Immunol. 21:211-218.
23. Muda, M., U. Boschert, R. Dickinson, J. C. Martinou, I. Martinou, M. Camps, W. Schlegel, and S. Arkinstall. 1996. MKP-3, a novel cytosolic protein-tyrosine phosphatase that exemplifies a new class of mitogen-activated protein kinase phosphatase. J. Biol. Chem. 271:4319-4326.
24. Sun, H., C. H. Charles, L. F. Lau, and N. K. Tonks. 1993. MKP-1 (3CH134), an immediate early gene product, is a dual specificity phosphatase that dephosphorylates MAP kinase in vivo. Cell 75:487-493.
25. Zhao, Q., X. Wang, L. D. Nelin, Y. Yao, R. Matta, M. E. Manson, R. S. Baliga, X. Meng, C. V. Smith, J. A. Bauer, et al. 2006. MAP kinase phosphatase 1 controls innate immune responses and suppresses endotoxic shock. J. Exp. Med. 203:131-140.
26. Kane, M. M., and D. M. Mosser. 2001. The role of IL-10 in promoting disease progression in leishmaniasis. J. Immunol. 166:1141-1147.
27. Nylén, S., and D. Sacks. 2007. Interleukin-10 and the pathogenesis of human visceral leishmaniasis. Trends Immunol. 28:378-384.
28. Yang, Z., D. M. Mosser, and X. Zhang. 2007. Activation of the MAPK, ERK, following Leishmania amazonensis infection of macrophages. J. Immunol. 178:1077-1085.
29. Brondello, J. M., J. Pouysségur, and F. R. McKenzie. 1999. Reduced MAP kinase phosphatase-1 degradation after p42/p44MAPK-dependent phosphorylation. Science 286:2514-2517.
30. Marchetti, S., C. Gimond, J. C. Chambard, T. Touboul, D. Roux, J. Pouysségur, and G. Pagès. 2005. Extracellular signal-regulated kinases phosphorylate mitogenactivated protein kinase phosphatase 3/DUSP6 at serines 159 and 197, two sites critical for its proteasomal degradation. Mol. Cell. Biol. 25:854-864.
31. Nelin, L. D., X. Wang, Q. Zhao, L. G. Chicoine, T. L. Young, D. M. Hatch, B. K. English, and Y. Liu. 2007. MKP-1 switches arginine metabolism from nitric oxide synthase to arginase following endotoxin challenge. Am. J. Physiol. Cell Physiol. 293:C632-C640.
32. Wang, X., X. Meng, J. R. Kuhlman, L. D. Nelin, K. K. Nicol, B. K. English, and Y. Liu. 2007. Knockout of Mkp-1 enhances the host inflammatory responses to gram-positive bacteria. J. Immunol. 178:5312-5320.
33. Sacks, D., and C. Anderson. 2004. Re-examination of the immunosuppressive mechanisms mediating non-cure of Leishmania infection in mice. Immunol. Rev. 201:225-238.
34. Hammer, M., J. Mages, H. Dietrich, F. Schmitz, F. Striebel, P. J. Murray, H. Wagner, and R. Lang. 2005. Control of dual-specificity phosphatase-1 expression in activated macrophages by IL-10. Eur. J. Immunol. 35:2991-3001.
35. Denkert, C., W. D. Schmitt, S. Berger, A. Reles, S. Pest, A. Siegert, W. Lichtenegger, M. Dietel, and S. Hauptmann. 2002. Expression of mitogenactivated protein kinase phosphatase-1 (MKP-1) in primary human ovarian carcinoma. Int. J. Cancer 102:507-513.
36. Vicent, S., M. Garayoa, J. M. López-Picazo, M. D. Lozano, G. Toledo, F. B. Thunnissen, R. G. Manzano, and L. M. Montuenga. 2004. Mitogenactivated protein kinase phosphatase-1 is overexpressed in non-small cell lung cancer and is an independent predictor of outcome in patients. Clin. Cancer Res. 10:3639-3649.
37. Wang, Z., J. Xu, J. Y. Zhou, Y. Liu, and G. S. Wu. 2006. Mitogen-activated protein kinase phosphatase-1 is required for cisplatin resistance. Cancer Res. 66:8870-8877.
38. Warmka, J. K., L. J. Mauro, and E. V. Wattenberg. 2004. Mitogen-activated protein kinase phosphatase-3 is a tumor promoter target in initiated cells that express oncogenic Ras. J. Biol. Chem. 279:33085-33092.
39. Xu, S., T. Furukawa, N. Kanai, M. Sunamura, and A. Horii. 2005. Abrogation of DUSP6 by hypermethylation in human pancreatic cancer. J. Hum. Genet. 50:159-167.
40. Keyse, S. M. 2008. Dual-specificity MAP kinase phosphatases (MKPs) and cancer. Cancer Metastasis Rev. 27:253-261.
41. Kar, S., A. Ukil, G. Sharma, and P. K. Das. 2010. MAPK-directed phosphatases preferentially regulate pro- and anti-inflammatory cytokines in experimental visceral leishmaniasis: involvement of distinct protein kinase C isoforms. J. Leukoc. Biol. 88:9-20.